NCI Events
Featured Event

DCP Early Career Scientist Spotlight Research Seminar Series
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) has created the DCP Early Career Scientist Spotlight Research Seminar Series to highlight nominated early career scientists who are advancing research within the areas supported by DCP. The overall goal of this ongoing seminar series is to increase visibility and provide recognition to these DCP Early Career Scientists.
Need an Event Site?

Upcoming Events
(Displaying 11 out of 11 results)June 2025

Beyond Mammals: Exploring Cancer Models Webinar Series
The "Beyond Mammals: Exploring Cancer Models" webinar series will feature three sessions, each focusing on a non-mammalian animal model's relevance to cancer research, with three researchers presenting their experiences. The discussions, moderated by DCB program staff, will explore the uniqueness of these models, key differences from human cancer, and challenges in their adoption by researchers.

2025 Breast Cancer SPORE Investigators Workshop
Sponsored by the Translational Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI). The main goals of the workshop are to: 1. Identify challenges and knowledge gaps in Breast translational research; 2. Highlight advances in the field; 3. Define resources and technologies; and 4. Foster collaborations among the Breast Cancer SPORE sites, patient advocates, and NCI staff.
July 2025

Teaching in Medical Education (TIME)
Many postdoctoral fellows are considering an academic career at a medical school. In addition to conducting research, new faculty members must learn effective teaching methodologies. This course will focus on good teaching practices, including basic strategies for developing and organizing a course. The purpose of the "Teaching in Medical Education (TIME)" course is to increase the scientist's ability to teach in medical education. The course will provide basic knowledge in teaching methods, course planning, writing a syllabus and developing examinations.

Cancer AI Conversations
“Cancer AI Conversations” are bimonthly, 1-hour virtual events featuring timely topics related to the application of artificial intelligence in cancer research. Each event features short talks from 2-4 subject matter experts offering diverse perspectives on the session topic. These talks will be followed by a moderated panel discussion.
August 2025

Using the NCI Method for Measurement Error Adjustment
Using the NCI Method for Measurement Error Adjustment is a 5-day workshop being held at the NCI Shady Grove Campus in Rockville, MD. In current practice, assessments of modifiable risk factors for cancer, like physical activity and nutrition, are subject to substantial amounts of measurement error for which simple corrections are infeasible or impossible. Ignoring these errors can lead to spurious results and incorrect conclusions about associations with cancer outcomes.
September 2025

Fall 2025 NCI Early Drug Development
The NCI CTEP Early Drug Development Meeting is held annually to enhance communication between NCI and the network of ETCTN investigators that conduct CTEP-sponsored early phase clinical trials. The meeting is open to academic, government, and pharmaceutical clinical investigators and related health care personnel (e.g., nurses, statisticians, translational scientist, etc.) involved in CTEP funded oncology early drug development. The focus of the meeting is on prioritizing investigational agent selection and targeting, novel trial designs, and development and implementation of translational studies, as well as on new therapeutic and imaging modalities. The data presented at the meeting is considered a private communication, and the information should not be disseminated for public use.

Transformative Microsystems for Cancer Diagnosis, Treatment Monitoring, and Clinical Integration
This workshop will bring together scientists, clinicians, engineers, patients, survivors, and advocates to explore cutting-edge microsystem technologies that are transforming cancer diagnostics, treatment monitoring, and disease management.

Childhood Cancer: NCI Office of Data Sharing (ODS) Inaugural Data Jamboree
Come and join us at the NCI's Office of Data Sharing (ODS) on September 29-30. The overall goal of this 1.5-day in-person event is to increase the visibility of a variety of childhood cancer datasets, promote interdisciplinary collaborations, and accelerate scientific innovation through enhanced data sharing and use, This ODS inaugural event will focus on solving specific problems in childhood cancer.

NCI's Office of Data Sharing Annual Symposium
Sept. 30th - Oct. 1st. A foundational shift to a culture of broad data sharing and collaborative science holds immense promise for more rapid advances in cancer research. NCI’s Office of Data Sharing will bring together experts and stakeholders including scientists, clinicians, policymakers, patients, advocates and trainees across government, academia and industry to learn from one another and explore ways to maximize the benefits of these efforts.

CPTAC Scientific Symposium Public
The National Cancer Institute’s Office of Cancer Clinical Proteomics Research (OCCPR) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) are pleased to announce the 2025 CPTAC Scientific Symposium. Join us on September 30, 2025 to learn about the most current advances in the field of cancer proteogenomics and cancer research by our CPTAC investigators. While this meeting is in-person for CPTAC consortium and NIH participants, only virtual option is available for public attendees.
February 2026

Consortium for Cancer Implementation Science Annual Meeting
The Consortium for Cancer Implementation Science (CCIS) annual meeting taking place in-person from February 26-28, 2025, in Winston-Salem, North Carolina will be hosted by Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist Comprehensive Cancer Center. The annual meeting provides an opportunity for researchers, practitioners, and investigators to collaborate and advance the field of implementation science (IS) in cancer.